Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer
| Publication | Article in Anti-Cancer Agents in Medicinal Chemistry, published December 2024 |
|---|---|
| Authors | Surya K. De |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…